Salmonella Enteritidis (SE) is one of the most common causes of bacterial food-borne illnesses in the world. Despite the SE’s ability to colonize and infect a wide-range of host, the most common source of infection continues to be the consumption of contaminated shell eggs and egg-based products. To date, the role of the source of SE infection has not been studied as it relates to SE pathogenesis and resulting disease. Using a streptomycin-treated mouse model of human colitis, this study examined the virulence of SE grown in egg yolk and Luria Bertani (LB) broth, and mouse feces collected from mice experimentally infected with SEE1 (SEE1 passed through mice). Primary observations revealed that the mice infected with SE grown in egg yolk displayed greater illness and disease markers than those infected with SE passed through mice or grown in LB broth. Furthermore, the SE grown in egg yolk achieved higher rates of colonization in the mouse intestines and extra-intestinal organs of infected mice than the SE from LB broth or mouse feces. Our results here indicate that the source of SE infection may contribute to the overall pathogenesis of SE in a second host. These results also suggest that reservoir-pathogen dynamics may be critical for SE’s ability to establish colonization and priming for virulence potential.
Citation: Moreau MR, Wijetunge DSS, Bailey ML, Gongati SR, Goodfield LL, Hewage EMKK, et al. (2016) Growth in Egg Yolk Enhances Salmonella Enteritidis Colonization and Virulence in a Mouse Model of Human Colitis. PLoS ONE 11(3): e0150258. https://doi.org/10.1371/journal.pone.0150258
Editor: Yung-Fu Chang, Cornell University, UNITED STATES
Received: October 28, 2015; Accepted: February 5, 2016; Published: March 3, 2016
Copyright: © 2016 Moreau et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Data Availability: All relevant data are within the paper.
Funding: This work was supported by the National Integrated Food Safety Initiative, U.S. Department of Agriculture to SK (award number 2011-51110-3099). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing interests: The authors have declared that no competing interests exist.
Salmonella enterica serovar Enteritidis (SE) is a Gram-negative, peritrichous, facultative anaerobic, enteric bacterial pathogen. It is the most common cause of salmonellosis in the world making it a major cause of food-borne morbidity and mortality globally [1,2,3,4]. Salmonella Enteritidis has an extensive host range and remains an important pathogen for humans and many animal species [5,6]. In the United States alone, the number of SE cases in humans has increased by 44% in the last 20 years .
In most cases, SE causes a self-limiting gastroenteritis, which presents with symptoms, such as diarrhea, abdominal cramps, and dehydration. It is not usually fatal although immunocompromised individuals as well as the extremely young or elderly are at high risk for complications of the disease due to systemic dissemination of SE and deficiencies from dehydration [1,5]. If left untreated, these complications can be fatal to these at risk groups. It is estimated that 1:20,000 eggs are contaminated with SE and with approximately 65 billion eggs produced each year in the U.S. alone, about 3.25 million eggs are potentially contaminated. In the 1970’s, surveillance programs and stringent cleaning practices helped to limit the number of illnesses due to egg shell-contamination, however the percentage of internally infected eggs and related illnesses are currently on the rise .
Chickens can be born SE infected or acquire SE from the environment via fecal-oral route after hatching [8,9]. Infected hens and rodents, such as mice and rats shed SE in their feces, intermittently contaminating the poultry house environment [10,11]. Rodents are considered one of the biggest risk factors for introduction of SE to poultry and they are likely the source of many plant or produce-based outbreaks of SE [10,12]. Despite the high prevalence of SE in the environment and in animals that are in constant contact with humans, the most important source of SE infections of people remains the shell eggs and egg-based products . Unlike its close relative, Salmonella Typhi, there is not much evidence of human to human spread or rodent to human spread through fecal desiccation and dust, which leads to the question of why shell eggs and their products are the major driver of SE transmission to humans. The rise in number of internally infected eggs and human cases suggests a link between the two phenomena. Recent studies have shown that the virulence profile of SE is enhanced when grown inside of an egg. According to a phenotypic microarray, the nutrients within the egg yolk may trigger the expression of certain virulence genes through biochemical linkage [14,15]. Furthermore, a study performed by Gantois and colleagues indicated that growth inside the egg causes SE to express pef- fimbriae in S. Typhimurium, which has been shown to be important during colonization in the mouse intestines [16,17].
The study presented here was conducted to examine the effect that a particular source microenvironment plays on SE infection in the human host by studying the overall pathogenesis and colonization potential of SE by using a mouse model of human SE colitis, as it relates to the source. This study has far-reaching implications to host-pathogen dynamics in relation to pathogen transmission events and may help us better understand the population genetics, epidemiology, and pathogenic strategies employed by SE and possibly other bacterial pathogens. It will also aid in understanding evolutionary events that allow SE to conserve genes that give it a consistently broad host range, and allow future research to focus on potential eukaryotic targets during the infection process.
Materials and Methods
Bacterial strains, and media, and preparation of bacterial innocula
A recently sequenced and characterized SE strain, SEE1 (Salmonella Enteritidis isolated from egg; NCBI accession number CP011790), was used in this study . Bacterial inoculations were prepared from SE grown under three different conditions; SE grown in a bacteriologic medium, SE grown in egg yolk, and SE passed through mice. The bacteriologic medium used was Luria Bertani (LB) broth (BD Diagnostics). Bacteria were grown in LB broth overnight at 37°C with continuous shaking. The SE grown in LB broth was subcultured 1:100 into fresh LB broth and grown to an OD600 of 1.0. Bacterial pellets were collected by centrifugation at 12,000 xg and resuspended in phosphate-buffered saline (PBS, pH 7.0) (Amresco). To prepare the inoculum of SE passed through mice, mice were first infected with SEE1 after treating with streptomycin as described under “Mouse Experiments and Bacterial Enumeration” section below. Feces from each infected mice was collected separately and aliquots were plated onto xylose lysine deoxycholate (XLD) agar (Hardy Diagnostics) to ensure the presence of SE in the feces. Then, the fecal samples were pooled and organic matter was removed by homogenization by use of Stomacher 80™ bags with a 0.5 mm filter (Seward Limited). The filtrate free of organic matter was used as the inoculum. To grow SE in egg yolk, eggs from organically raised chickens were used. Briefly, egg yolk was separated from albumen and placed in a sterile 50 ml conical tube (Corning). Egg yolk was then inoculated with an isolated colony of SEE1 grown on MacConkey agar (Hardy Diagnostics) and grown overnight at 37°C with shaking. The final inocula were prepared by adjusting the bacterial concentrations in each source to ~107CFU of SE per 50 μl with PBS. To determine the absolute bacterial counts in each inoculum, serial dilutions were made in PBS and plated on XLD agar.
Mouse experiments and bacterial enumeration
All of the procedures involving mice were conducted as described previously with a few exceptions . Briefly, 6–8 week old C57/B6 mice (Jackson Laboratory) were treated with 20 mg/50 μl/mouse with pharmaceutical grade streptomycin (X-GEN Pharmaceuticals) resuspended in sterile distilled water by oral gavage. This animal model was used because of its susceptibility to many broad host range Salmonella species [19,20]. It has been successfully used by other investigators to reproduce bacterial colitis commonly seen during human infection due to SE [20, 21]. Twenty four hours after treatment with streptomycin, groups of at least three mice were then infected with approximately 5x107 CFU of SEE1 grown in LB broth, egg yolk, or mouse feces containing SEE1 by oral gavage. Control mice inoculated with 50 μl of PBS, egg yolk, or feces not containing SEE1 to control for any effects the background media may cause to the mice. Mice were given food and water ad libitum except for 4 hours prior to and 2 hours following oral gavaging. The experiment was replicated three times with three to five mice per group. The first two replicates had five mice per group and the last replicate had four mice per experimental group and three mice per control group. Mice were observed for 48 hours post-infection, mortalities were recorded, and surviving mice were euthanized by CO2 asphyxiation for necropsy examination and tissue collection. Gross pathological lesions of the organs were recorded and sections of intestines (small intestine, large intestine), liver, and spleen were placed in 10% neutral buffered formalin for histopathology.
Organs were subsequently pooled [by tissue type (liver, spleen, small intestine and the cecum section of the large intestine separate from the colon) and by experimental group], weighed, and placed in Stomacher 80 bags with a filter and homogenized in 1 ml of PBS in a stomacher for bacterial recovery and enumeration. Fecal pellets were collected from each mouse immediately before euthanasia and homogenized in PBS. Serially diluted samples were subsequently plated on XLD agar without antibiotics and plated in triplicate. Black colonies grown on XLD plates were considered as SE and selected for counting. For final statistical analysis, data from three replicates were combined. Therefore, experimental groups contained 14 mice per group and control groups contained 13 mice per group. Data collected were then analyzed using GraphPad Prism Software v. 5.0 (GraphPad Software, Inc.) by either One-Way ANOVA with Tukey’s pairwise comparison post-test for tissues and Kruskal-Wallis with a Dunn’s pairwise comparison post-test for fecal counts as these were taken from individual mice with a significant difference set at p<0.05.
Animal experiments were carried out in strict accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health. The protocol was approved by the Institutional Animal Care and Use Committee (IACUC) at the Pennsylvania State University (Protocol Number: 45500). All animals were housed in accordance with the American Association for Laboratory Animal Care standards in groups of up to five animals in individually ventilated cages and kept in a temperature controlled environment (22–24°C) in an animal facility for infected mice. Experiments were planned and conducted utilizing the three R's (reduce, replace and refine) and all efforts were made to minimize animal suffering. Per the IACUC and experimental protocols, the endpoint for each experiment was 48 hours post-infection. If any mice met with two or more clinical symptoms of disease (such as ruffled fur, moribund nature, labored breathing) were to be sacrificed before end of the experiment. However, mice did not show outward signs of disease until 48 hours post-infection. The method of euthanasia was CO2 asphyxiation followed by dissection to ensure death. Mice were monitored every 4–8 hours after antibiotic treatment and infection.
Slides for histopathology were made from formalin-fixed paraffin-embedded (FFPE) sections of the ceca from each mouse at the Animal Diagnostic Laboratory (The Pennsylvania State University). Slides were made with the tissues collected from the last replicate, stained with hematoxylin and eosin (H&E), and viewed with an Olympus BX51 System Microscope (Olympus America, Inc.) at 400x. Twelve to fifteen fields of view for a minimum of three mice per experimental group (four mice per experimental group and three mice per control group) were photographed and analyzed using CellSens Software (Olympus America, Inc.). Total histopathology was scored based on a scoring system developed by Barthel and colleagues . In short, each field was scored on the basis of polymorphonuclear leukocyte (PMN) infiltration of the lamina propria, number of goblet cells, epithelial integrity, and submucosal edema as shown in Table 1. Scores were added, averaged and analyzed by one-way ANOVA with a Tukey’s pairwise comparison test. Statistical significance was considered at p<0.05.
Enzyme-linked immunosorbent assays.
Enzyme-linked immunosorbent assays (ELISAs) were performed using DuoSet (R&D Systems) ELISA kits for IFN-γ, IL-1β, and IL-10. All ELISAs were performed using the manufacturer’s instructions in flat bottom 96 well plates (BD Falcon). Pooled cecal homogenate samples from the third replicate (four mice per experimental group and three mice per control group) were diluted 1:2 in PBS and loaded in triplicate for each cytokine. Final optical densities were read using a 450 nm filter on an ELx808 96-well Plate Reader (BioTek Instruments Inc.). Readings were first normalized to the background of the plate. These adjusted readings were used to calculate concentrations of each cytokine in pg/ml based on a standard curve for each cytokine, which were then normalized to the average weight of the ceca of the group. The average cecal weight per group was determined by adding the total weight of the pooled ceca divided by the number of mice in each group. These values were then normalized to the values obtained for their respective controls (formula given below). Data were analyzed by Tukey’s pairwise comparison test following ANOVA and p-values<0.05 were considered significantly different.
X = Average pg of cytokine
B = pg cytokine/mL
A = Average cecal weight of the group
D = Dilution factor
C = Average control [cytokine]
N = Number of mice in the group
*Note is to calculate individual sample [cytokine]
Gross pathology and biometrics
Photographs of mice and ceca from the third replicate (four mice per experimental group and three mice per control group),were taken using a D5200 Nikon digital camera at the time of necropsy to determine the gross pathological lesions. Ceca were placed on a graph paper in comparison to a ruler in order to measure cecal size differences among different treatment groups before taking the photographs. Percentage weight change of the mice was calculated by the formula below. Mice were ear punched to keep track of the individual mice and the weight of each mouse was recorded at the beginning of the experiment (after streptomycin treatment, prior to infection).
x = Average % Body weight change
B = Change in body weight
A = Original body weight
C = Percent body weight change average of control
N = number of mice in the group
*Note is to calculate % body weight change per mouse
Salmonella Enteritidis grown in egg yolk displays enhanced colonization of the mouse intestines
We first sought to establish if the growth medium or source of SE would have an effect on its ability to colonize the mouse intestines. In a streptomycin-treated mouse model of SE-induced colitis, SEE1 grown in all three sources (egg yolk, mouse feces, and LB broth) were able to colonize the mouse intestines (Fig 1A, 1B and 1C). The degree of colonization of the small intestine by SE was much less than in the cecum and colon. The mice infected with SEE1 grown in egg yolk displayed a greater colonization in the mouse intestines compared to the groups infected with SE in mouse feces or SE grown in LB broth. The difference in each of the intestinal tissues was approximately one log-fold or greater between the groups infected with SEE1 grown in egg yolk and SEE1 from the other sources. No significant difference was observed between the groups treated with SEE1 grown in LB broth and SEE1 from mouse feces.
Above are the results of the bacterial burden in the mouse intestines after infecting with SEE1 from different sources. Bacterial counts of the small intestine (A), cecum (B), colon (C) as well as fecal shedding differences (D) were taken from three experiments, normalized with corresponding controls, and the results analyzed by one-way ANOVA with a Tukey’s post-test (A-C) or Kruskall-Wallis test (D) and * represents p<0.05. There were five mice per group in the first two experiments and four mice per group in the last experiment. Mice that received the same treatment in each of the three experiments were considered one group for final data analysis.
Salmonella Enteritidis grown in egg yolk increases fecal shedding
Due to the increase in GIT colonization observed for SEE1 grown in egg yolk, we next probed for differences in ratios of fecal shedding. There was an increase in fecal shedding (CFU/g) of SEE1 from mice infected with SEE1 grown in egg yolk compared to the other two sources (Fig 1D). Similar to the difference observed in the colonization of the intestines, the group infected with SEE1 from egg yolk demonstrated at least 1-log-fold difference in shedding compared to SEE1 grown in LB broth or from mouse feces.
SEE1 grown in egg yolk shows variable increase in dissemination
Salmonella Enteritidis has the ability to disseminate to extra-intestinal sites, such as the liver and spleen, and thus we determined if the source of SEE1 had an influence on its extra-intestinal dissemination. SEE1 grown in egg yolk was found to colonize the mouse liver to a significantly greater degree when compared to SEE1 from the other two sources, although the difference was less than 1-log (Fig 2A). There was no statistical significance in colonization of the spleen among SEE1 grown under the three different conditions examined in this study (Fig 2B).
Bacterial burden of the liver (A) and spleen (B) from three experiments was taken and normalized with corresponding controls, and analyzed by Tukey’s post-test of one-way ANOVA, and significance of p<0.05 is indicated by *. There were five mice per group in the first two experiments and four mice per group in the last experiment. Mice that received the same treatment in each of the three experiments were considered one group for final data analysis.
Growth in egg yolk enhances SEE1 virulence in vivo
Mice infected with SEE1 from yolk showed more serious symptoms of disease and were more likely to be moribund than SEE1 from LB broth or feces. Mice infected with SEE1 grown in egg yolk retained more body weight than the mice infected with SEE1 from two other sources (Fig 3). To further study differences in pathogenesis between groups, biometric markers of inflammation and infection were measured.
The overall weight of mice is an indicator of gastrointestinal distress of mice. Mice from the third experiment (four mice in each experimental group and three mice in each control group) were weighed at the beginning and end of the experiment with SEE1 from various sources and the difference was compared to respective controls. The weight changes were taken from at least two experiments, normalized with corresponding controls, expressed as percent weight changes, and analyzed by Tukey’s pairwise comparison test following a one-way ANOVA. Significance was considered for p<0.05 and shown as *.
Distinct changes were observed in the gross pathology of the internal organs, with the most striking differences seen in the ceca and liver. Mice infected with SEE1 from yolk displayed signs of inflammation (whitish color edema and prominent blood vessels) in the liver, whereas livers of the mice in other groups appeared healthy (Fig 4). Similarly, the ceca of the mice infected with SEE1 from yolk were extremely pale, shriveled, and emptied; while mice in other experimental groups had enlarged ceca with signs of mild inflammation (Fig 4 and Fig 5C1–5C3). This observation was further supported by the overall dimensional changes of the ceca. On average, ceca infected with SEE1 from egg yolk were significantly lighter (by weight) and smaller (in length) compared to ceca from the other two infected groups (Fig 5A and 5B). In both the ceca and the liver of the mice infected with SEE1 grown in egg yolk, blood vessels were very prominent indicating severe inflammation at these sites. Similarly, most of the viscera of the peritoneal cavity displayed signs of inflammation (edema and paling) as well as evidence of toxemia and increased perfusion.
Overall changes in the mice internal organs from the third experiment were photographed and analyzed. Mice infected with SEE1 grown in egg yolk (B) appear to have greater outward pathology than the mice infected with SEE1 from LB broth (A) or from mouse feces (C). Major changes in gross pathology and organs of interest are indicated by the arrows and Roman numerals. I, The liver displaying marked paling, and prominent blood vessels. II, The small intestine showing signs of paling compared to the small intestine in A and C. III, The cecum that is emptied and shriveled. IV, The colon section of the large intestine that is extremely pale and empty. V, Fluid build-up in the visceral tissues. There were four mice in each experimental group and three mice in each control group.
The overall size (A), weight (B), and pathology-driven morphological changes (C1-C3) were determined for the mice infected with SEE1 from the three sources. There were four mice in each experimental group and three mice in each control group. Measurements of the ceca from the last experiment were taken and normalized with corresponding controls, yielding the changes in size and weight. SEE1 grown in egg yolk appears to cause greater pathological changes in the ceca as compared to SEE1 grown in LB broth (C1) or passed through mice (C3). For A and B, significance was determined by one-way ANOVA Tukey’s pairwise comparison test, and significance was set at p<0.05; indicated by *.
To associate the inflammatory changes seen in the cecum to inflammatory response, cecal homogenates were subjected to cytokine analysis by ELISA to test for levels of interferon gamma (IFN-γ), Interleukin-1 beta (IL-1β), and interleukin-10 (IL-10). As shown in Fig 6, the levels of IL-1β and IFN-γ were significantly higher in the ceca of mice infected with SEE1 from yolk in comparison to other groups. This change correlated to the suppression of IL-10. With the increases in gross pathology and biometrics in the mice infected with SEE1 from yolk, cellular damage was assessed using histopathology. Ceca from individual mice were sectioned and scored based on a previously defined scoring system. By quantitative (Fig 7) and qualitative (Fig 8) microscopic analysis of these sections revealed that SEE1 from yolk resulted in more lesions and more severe pathology in mice at the cellular level than in mice infected with SEE1 from LB broth or mouse feces.
Pro-inflammatory and anti-inflammatory cytokine profiles had been determined by ELISA for ceca of mice infected with SEE1 from egg yolk (four mice), LB broth (four mice), and passed through mice (four mice) as well as corresponding controls for each source used (three mice each). Results were normalized with corresponding controls and analyzed through one-way ANOVA and subsequent Tukey’s Pairwise Comparison Test. Significance of p<0.05 is indicated by *.
The primary site of colonization for SE in mice is the cecum; so the histopathology of the ceca of three mice from each control group and four mice from each infection group was determined. Statistical significance was determined by one-way ANOVA Tukey’s pairwise comparison test, and significance was set at p<0.05; indicated by *.
This Fig shows a representative micrographs of sections of a healthy ceca from an uninfected mouse (A), and cecal sections of mice infected with SEE1 grown in egg yolk (B), SEE1 passed through mice (C), and SEE1 grown in LB broth (D). Abbreviations: GC (Goblet Cells), EP (Epithelial Cells), LP (Lamina Propria), TM (Tunica Muscularis), MM (Muscularis Mucosa), PMN (Polymorphonuclear leukocytes), SME (Sub-mucosal Edema), UL (Ulceration).
Salmonella Enteritidis remains a constant threat to human and animal health [7,13, 22]. For humans, the predominant cause of bacterial-foodborne morbidity and mortality is non-typhoidal Salmonella enterica infections, of which SE is the most common . Despite the fact that SE can infect a wide range of host species and evidence that humans acquire SE from a wide-range of vectors, shell eggs and egg-based products remain the primary vehicles of transmission of SE to humans [5,9,13]. Why shell eggs and egg products remain the most common source of SE-associated foodborne illness has yet to be understood from the standpoint of pathogen transmission dynamics and disease pathogenesis. To our knowledge, there has never been a study that has probed the effect of pathogen source on SE virulence and pathogenesis.
As a non-typhoidal Salmonella enterica serovar, SE primarily causes gastrointestinal disease but can disseminate to the liver and spleen through the lymphatic system . Studies conducted using a streptomycin-treated mouse model of Salmonella colitis have revealed that for non-typhoidal Salmonella enterica serovars, such as Typhimurium and Enteritidis, the primary site of colonization is the cecum, but they can also be recovered from the other intestinal sites, extra-intestinal sites, and lymphatic tissues [19,24]. The ability of SE to colonize its host and cause disease is determined by genes located primarily on five major pathogenicity-associated islands (PAI) though some virulence factors are located outside of these PAI . Among the five major PAIs, Salmonella Pathogenicity Islands 1 and 2 (SPI1 and 2) are essential for the ability of SE to colonize and spread .
For a Gram-negative bacterial species like SE, initial colonization is crucial. The site of SE colonization creates a microenvironment rich in LPS, toxins, and other effectors as a result of collateral damage via pro-inflammatory cytokines and neutrophils . Because bacterial gene expression is determined by its environment, the source of SE may have an effect on SE virulence in the subsequent host. This study in fact demonstrated for the first time that the source of SE influences the subsequent disease pathogenesis in the host. The mouse intestines had significantly higher colonization by SEE1 from yolk than SEE1 from LB broth or passed through mice. The fact that SEE1 grown in egg yolk also had colonized the liver to a significantly greater extent as compared to SEE1 from the other sources also meant that the microenvironment of egg yolk increased the virulence of SE including its colonization and invasive abilities perhaps by upregulation of respective virulence genes. Other evidence in support of this hypothesis is shown by the degree of damage to the organs in mice infected with SEE1 from egg yolk as compared to the mice infected with SEE1 from LB broth or feces. The organs of mice infected with SEE1 from egg yolk have increased signs of inflammation and necrosis; most notably in the cecum (primary site of colonization for SE) and the liver (primary site of disseminated colonization for SE) as shown in Figs 4 and 5. The quantitative and qualitative histopathological lesions of the cecum were in consistent with the gross pathological observations as evidenced by a significant increase in the overall inflammation of the cecum in mice infected with SEE1 from egg yolk as compared to SEE1 from other two sources. Inflammation and cellular damage is more severe and widespread in these mice compared to those infected with SEE1 grown in LB broth or passed through mice.
Mice infected with SEE1 from yolk also displayed several histopathological markers consistent with increased virulence. The ceca showed more erosion and ulceration of the epithelium, including loss of epithelial integrity as compared to mice in other experimental groups. Additionally, PMN infiltration of the lamina propria of the cecum was pronounced. Of note, however, was that mice infected with SEE1 that was passed through mice showed significantly less histopathological lesions compared to SEE1 from egg yolk or LB broth in spite of no difference in colonization abilities. Differences in microscopic and macroscopic pathology between groups correlated with cytokine expression. All SE infected mice irrespective of the source of SE were able to stimulate production of pro-inflammatory cytokines, such as IL-1β (in response to LPS) and IFN-γ (in response to intracellular pathogens) compared to uninfected controls. Just like the damage and inflammation that was seen previously, SEE1 from yolk elicited a stronger pro-inflammatory cytokine response as well as a strong suppression of the anti-inflammatory cytokine IL-10. However, SEE1 from LB broth or feces was attenuated in their cytokine response as compared to SEE1 from yolk.
Taken together, these results suggest that the source of an SE infection plays a significant role in the pathobiology of that host-pathogen interaction, resulting in significant differences in overall disease outcome. It can be inferred that these changes most likely occur at the point of SE transmission leading to a change in the disease kinetics rather than a continuous change over the course of the infection. This is because at the time of transmission, SE’s transcriptional program will be the same as it was in the yolk and later during the infection this program will adapt to the microenvironment of the host. It is worth noting that these data support the novel finding that SE passed through mouse is attenuated in virulence compared to SE from the other two sources. This is in contrast to what has been seen previously with other Salmonella enterica serovars as well as other enteric Gram negative bacteria such as Vibrio cholerae where inter-species passage actually increases colonization and virulence .
Of the five major PAIs found within SE, SPI-1 is essential for invasion and initial colonization, and SPI-2 is essential for dissemination and macrophage survival . Both SPIs are regulated by a number of well-known signal response systems including PhoP/Q, LsrR, QseB/C, and oxygen tension [28–31]. The SPI-1 is also co-regulated with SPI-4 . We hypothesize that the high cell density of SE (109CFU/ml) will activate the autoinducer-1 (AI-1) and subsequently, the AI-2 systems in combination with low oxygen levels in egg yolk will upregulate the expression of SPI-1, 2, and 4 prior to transmission. Egg yolk is extremely nutrient-rich and likely supplies the energy required by SE to express all of the genes on these PAIs in response to these signals .
In the egg yolk, SE might become pre-programmed to cause infection in the human host due to the synthesis of the PAIs’ gene products, including two type III secretion systems and a plethora of effectors prior to colonization. This allows for quicker colonization, invasion, and initial damage prior to adapting genetically to the host, resulting in more severe lesions in the colonization sites like those seen in cecal histopathology. An increase in SPI-1expression in turn increases the level of the NF-κB antagonist AvrA, allowing the bacteria to colonize and invade the tissues without initial recruitment of inflammatory cells at the site of colonization . Once in these sites, these bacteria will downregulate SPI-1 and upregulate SPI-2, the mediator of many SE intracellular survival traits . This allows the infected cells to upregulate NF-κB regulated pro-inflammatory cytokines and recruits PMNs to the sites of infection. The PMN infiltration and subsequent oxidative burst damage the intestinal epithelial cells and microbiota releasing ethanolamine and tetrathionate into the lumen [35,36]. In this microenvironment, SE can dominate because it is protected against the oxidative burst by its superoxide dismutases and can use ethanolamine and tetrathionate to drive anaerobic respiration . This increase in initial colonization followed by subsequent events would explain the pronounced differences in damage seen in these mice from SEE1 grown in egg yolk as well as the strong pro-inflammatory response (by way of increase in pro-inflammatory cytokines as well as decrease of anti-inflammatory cytokines) in response to bacterial burden differences.
Altogether, this study illustrates two very important and novel findings related to microbial pathogenesis and specifically to SE pathogenesis. The first is that the source or reservoir of a bacterial pathogen can influence the outcome of disease in a new host. The second is that the increase in colonization and virulence of SE in mice after being grown in egg yolk may explain why shell eggs and egg products are the most common vehicle of SE transmission. More work must be done to explore the underlying mechanisms that SE uses to undergo this transcriptional programming event. More importantly, examining the relationship of the source-bacteria-host epidemiological triad is very important in understanding the overall disease pathogenesis.
We would like to thank the Animal Diagnostic Laboratory at The Pennsylvania State University for allowing us access to a high quality camera for necropsy photographs. A special thanks to Dr. Vijay Kumar for his advice on ancillary experiments. We would like to thank undergraduate students, Stephanie Majernik, Kevin Burke, Alisha Scharf, Gabriel Silva, and Tushar Kim for assistance with experiments.
Conceived and designed the experiments: MRM BMJ SK. Performed the experiments: MRM DSSW MLB SRG LLG EMKKH MJK CF YVI JEL. Analyzed the data: MRM DSSW MJK SK. Wrote the paper: MRM BMJ SK.
- 1. CDC. Salmonella Serotype Enteritidis. National Center for Emerging and Zoonotic Infectious Diseases. 2010.
- 2. CDC. Vital Signs. 2011; Incidence and trends of infection with pathogens transmitted commonly through food. foodborne diseases active surveillance network, 10 U.S. sites, 1996–2010.
- 3. Desai PT, Porwollik S, Long F, Cheng P, Wollam A, Clifton SW, et al. Evolutionary genomics of Salmonella enterica subspecies. mBio. 2013 Mar 5;4(2). pii: e00579-12.
- 4. Deng X, Desai PT, den Bakker HC, Mikoleit M, Tolar B, Trees E, et al. Genomic Epidemiology of Salmonella enterica serotype Enteritidis based on population structure of prevalent lineages. Emerg. Infect. Dis. 2014; 20: 1481–1489. pmid:25147968
- 5. Foley SL, Johnson TJ, Ricke SC, Nayak R, Danzeisen J.Salmonella Pathogenicity and host adaptation in chicken-associated serovars. Microbiol Mol Biol Rev. 2013; 77: 582–607. pmid:24296573
- 6. Eswarappa SM, Janice J, Nagarajan AG, Balasundaram SV, Karnam G, Dixit N et al. Differentially evolved genes of Salmonella pathogenicity islands: insights into the mechanism of host specificity in Salmonella. PLoS ONE. 2008; 3: e3829. pmid:19050757
- 7. Chai SJ, White PL, Lathrop SL, Solghan SM, Medus C,McGlinchey BM, et al. Salmonella enterica serotype Enteritidis: increasing incidence of domestically acquired infections. Clin Infect Dis.2012; 54: S488–S497. pmid:22572674
- 8. Gast RK, Guraya R, Guard-Bouldin J, Holt PS, Moore RW. Colonization of specific regions of the reproductive tract and deposition at different locations inside eggs laid by hens infected with Salmonella Enteritidis or Salmonella Heidelberg. Avian Dis. 2007; 51: 40–44. pmid:17461265
- 9. Guard-Petter J. The chicken, the egg and Salmonella Enteritidis. Environ Microbiol. 2001; 3: 421–430. pmid:11553232
- 10. Meerburg BG, Kijlstra A. Role of rodents in transmission of Salmonella and Campylobacter. J Sci Food Agric. 2007; 87: 2774–2781.
- 11. Gopinath S, Carden S, Monack D. Shedding light on Salmonella carriers. Trends Microbiol. 2012; 20: 320–327. pmid:22591832
- 12. Trampel DW, Holder TG, Gast RK. Integrated farm management to prevent Salmonella Enteritidis contamination of eggs. J Appl Poult Res. 2014; 23: 353–365.
- 13. Foley SL, Nayak R, Hanning IB, Johnson TJ, Han J,Ricke SC. Population dynamics of Salmonella enterica serotypes in commercial egg and poultry production. Appl Environ Microbiol. 2011; 77: 4273–4279. pmid:21571882
- 14. Morales CA, Porwollik S, Frye JG, Kinde H, McClelland M, Guard-Bouldin J. Correlation of phenotype with the genotype of egg-contaminating Salmonella enterica serovar Enteritidis. Appl Environ Microbiol. 2005; 71: 4388–4399. pmid:16085829
- 15. Bochner BR. Global phenotypic characterization of bacteria. FEMS Microbiol Rev. 2009; 33: 191–205. pmid:19054113
- 16. Gantois I, Ducatelle R, Pasmans F, Haesebrouck F, Van Immerseel F. Salmonella enterica serovar Enteritidis genes induced during oviduct colonization and egg contamination in laying hens. Appl Environ Microbiol. 2008; 74: 6616–6622. pmid:18776023
- 17. Ledeboer NA, Frye JG, McClelland M, Jones BD. Salmonella enterica serovar Typhimurium requires the Lpf, Pef, and Tafi fimbriae for biofilm formation on HEp-2 tissue culture cells and chicken intestinal epithelium. Infect Immun. 2006; 74: 3156–3169. pmid:16714543
- 18. Moreau MR, Wijetunge DSS, Kurundu Hewage EMK, Jayarao BM, Kariyawasam S. Genome sequences of two strains of Salmonella enterica serovar Enteritidis isolated from shell eggs. Genome Announc. 2015; 3.
- 19. Barthel M, Hapfelmeier S, Quintanilla-Martínez L, Kremer M, Rohde M, Hogardt M, et al. Pretreatment of mice with streptomycin provides a Salmonella enterica serovar Typhimurium colitis model that allows analysis of both pathogen and host. Infect Immun. 2003; 71: 2839–2858. pmid:12704158
- 20. Suar M, Jantsch J, Hapfelmeier S, Kremer M, Stallmach T, Barrow PA et al. Virulence of broad- and narrow-host-range Salmonella enterica serovars in the streptomycin-pretreated mouse model. Infect Immun. 2006; 74: 632–644. pmid:16369020
- 21. Jaiswal S, Pati NB, Dubey M, Padhi C, Sahoo PK, Ray S, et al. The O-antigen negative ∆wbaV mutant of Salmonella enterica serovar Enteritidis shows adaptive resistance to antimicrobial peptides and elicits colitis in streptomycin pretreated mouse model. Gut Pathog. 2015; 7: 24. pmid:26346801
- 22. Vieira Aea. A resource to link human and non-human sources of Salmonella. WHO Global Foodborne Infections Network Country Databank. 2009.
- 23. Acheson D, Hohmann EL. Nontyphoidal salmonellosis. Clin Infect Dis. 2001; 32: 263–269. pmid:11170916
- 24. Silva CA, Blondel CJ, Quezada CP, Porwollik S, Andrews-Polymenis HL, Toro CS, et al. Infection of mice by Salmonella enterica serovar Enteritidis involves additional genes that are absent in the genome of serovar Typhimurium. Infect Immun. 2012; 80: 839–849. pmid:22083712
- 25. Suez J, Porwollik S, Dagan A, Marzel A, Schorr YI, Desai PT, et al. Virulence gene profiling and pathogenicity characterization of non-typhoidal Salmonella accounted for invasive disease in humans. PLoS ONE. 2013; 8: e58449. pmid:23505508
- 26. Godinez I, Raffatellu M, Chu H, Paixão TA, Haneda T, Santos RL, et al. Interleukin-23 orchestrates mucosal responses to Salmonella enterica serotype Typhimurium in the intestine. Infect Immun. 2009; 77: 387–398. pmid:18955477
- 27. Alam A, LaRocque RC, Harris JB, Vanderspurt C, Ryan ET, Qadri F, et al. Hyperinfectivity of human-passaged Vibrio cholerae can be modeled by growth in the infant mouse. Infect Immun. 2005; 73: 6674–6679. pmid:16177344
- 28. Sturm A, Heinemann M, Arnoldini M, Benecke A, Ackermann M, Benz M, et al. The cost of virulence: retarded growth of Salmonella Typhimurium cells expressing type III secretion system 1. PLoS Pathog. 2011; 7: e1002143. pmid:21829349
- 29. Moreira CG, Weinshenker D, Sperandio V. QseC mediates Salmonella enterica serovar Typhimurium virulence in vitro and in vivo. Infect Immun. 2010; 78: 914–926. pmid:20028809
- 30. Xu X, Hensel M. Systematic analysis of the SsrAB virulon of Salmonella enterica. Infect Immun. 2010; 78: 49–58. pmid:19858298
- 31. Choi J, Shin D, Kim M, Park J, Lim S,Ryu S. LsrR-mediated quorum sensing controls invasiveness of Salmonella Typhimurium by regulating SPI-1 and flagella genes. PLoS ONE. 2012; 7: e37059. pmid:22623980
- 32. Main-Hester KL, Colpitts KM, Thomas GA, Fang FC, Libby SJ. Coordinate regulation of Salmonella pathogenicity island 1 (SPI1) and SPI4 in Salmonella enterica serovar Typhimurium. Infect Immun. 2008; 76: 1024–1035. pmid:18160484
- 33. Collier-Hyams LS, Zeng H, Sun J, Tomlinson AD, Bao ZQ, Chen H, et al. Cutting edge: Salmonella AvrA effector inhibits the key proinflammatory, anti-apoptotic NF-κB pathway. J Immunol. 2002; 169: 2846–2850. pmid:12218096
- 34. Figueira R, Watson KG, Holden DW, Helaine S. Identification of Salmonella pathogenicity island-2 type III secretion system effectors involved in intramacrophage replication of S. enterica serovar Typhimurium: implications for rational vaccine design. mBio. 2013; 4: e00065–00013. pmid:23592259
- 35. Thiennimitr P, Winter SE, Winter MG, Xavier MN, Tolstikov V, Huseby DL, et al. Intestinal inflammation allows Salmonella to use ethanolamine to compete with the microbiota. Proc Natl Acad Sci U S A. 2011; 108: 17480–17485. pmid:21969563
- 36. Lopez CA, Winter SE, Rivera-Chávez F, Xavier MN, Poon V, Nuccio SP, et al. Phage-mediated acquisition of a type III secreted effector protein boosts growth of Salmonella by nitrate respiration. mBio. 2012; 3: e00143–00112. pmid:22691391
- 37. Sly LM, Guiney DG, Reiner NE. Salmonella enterica serovar Typhimurium periplasmic superoxide dismutases SodCI and SodCII are required for protection against the phagocyte oxidative burst. Infect Immun. 2002; 70: 5312–5315. pmid:12183590